UAB Looking For A Variety Of Patients For COVID-19 Clinical Trials
Infectious disease doctors at UAB said Tuesday they’re still looking for COVID-19 patients to join a number of clinical trials.
Currently, UAB is offering both inpatient and outpatient trials ranging from vaccines to treatments aimed at lessening the effects of the virus.
Dr. Sonya Heath, a professor of medicine in UAB’s Division of Infectious Diseases, said some of the outpatient trials could appeal to patients because they only require a single dose, four in-person visits and virtual check-ins.
One of the trials currently accepting patients involves convalescent plasma treatments, which take antibodies from recovered patients and injects them into patients who have COVID or those who have come into close contact with the virus.
“We are really asking the question: If you give high concentrations of antibody, is that beneficial in decreasing the severity of the illness and decreasing the likelihood that somebody will be hospitalized,” Heath said.
Other studies have shown that patients do better if their bodies generate an immune response to the virus.
“They have a shorter course of illness and their viral load is lower,” Heath said. “We know that generating an immune response is a good thing and decreases your symptoms and severity. Each of these studies … is looking at ways to transfer an immune response to you in some form or fashion.”
Dr. Turner Overton, from UAB’s outpatient COVID-19 clinic, says patients should enroll in clinical trials because it gives them a more heightened level of clinical care.
“We’re gaining knowledge and we have expertise here at UAB,” Overton said. “But if people sit at home and wait until they’re really sick, in the second week of illness, you know, the complications are much higher.”
UAB is looking for COVID-19 patients with varying degrees of symptoms.
Editor’s Note: UAB holds WBHM’s broadcast license but our news and business departments operate independently.
Viral global TikToks: A twist on soccer, Tanzania’s Charlie Chaplin, hope in Gaza
TikToks are everywhere (well, except countries like Australia and India, where they've been banned.) We talk to the creators of some of the year's most popular reels from the Global South.
This painting is missing. Do you have it?
An important work from a rediscovered artist has been absent from public view since the 1970s. A New York curator is hunting for it.
Memory loss: As AI gobbles up chips, prices for devices may rise
Demand for memory chips currently exceeds supply and there's very little chance of that changing any time soon. More chips for AI means less available for other products such as computers and phones and that could drive up those prices too.
Brigitte Bardot, sex goddess of cinema, has died
Legendary screen siren and animal rights activist Brigitte Bardot has died at age 91. The alluring former model starred in numerous movies, often playing the highly sexualized love interest.
For Ukrainians, a nuclear missile museum is a bitter reminder of what the country gave up
The Museum of Strategic Missile Forces tells the story of how Ukraine dismantled its nuclear weapons arsenal after independence in 1991. Today many Ukrainians believe that decision to give up nukes was a mistake.
Jeffrey R. Holland, next in line to lead Church of Jesus Christ of Latter-day Saints, dies at 85
Jeffrey R. Holland led the Quorum of the Twelve Apostles, a key governing body. He was next in line to become the church's president.
